Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2021

View Archived Issues

New anti-EGFRvIII antibodies patented by Regeneron Pharmaceuticals

Wuhan Optics Valley Yatai Pharmaceutical Research Institute patents HIF-2-alpha inhibitors

New ROCK1/2 inhibitors identified at Wuhan LL Science and Technology Development Co.

Bayer identifies new PTGER3 antagonists

Taisho Pharmaceutical presents new MMP-2 inhibitors

Optogenetic vector GS030-DP with light stimulation shows promise in retinitis pigmentosa patient

IMC-1 improves multiple fibromyalgia symptoms

Completion of target enrollment in part A of phase I/II study of MRx-4DP0004 in asthma

Surface Oncology and Roche collaborate on immune-oncology study evaluating SRF-388 in HCC

First subjects dosed in phase II study of ADV-110 in Australia

Localized production of protein therapeutics in tumor cells using the SHREAD gene therapy platform

Genome-wide screening identifies shared and specific host factors of SARS-CoV-2 and other CoVs

Boehringer Ingelheim initiates phase I study of BI-765049 alone or in combination with BI-754091

Sorrento Therapeutics and Karolinska Institutet collaborate on iPSC-derived DAR-NK cells

BTK-selective degrader NX-5948 reduces inflammation in a murine model of rheumatoid arthritis

China's NMPA clears IND for FXR agonist ASC-42 for chronic hepatitis B

Enrollment begins in phase I study of RO-7300490 as single agent or in combination with atezolizumab

New phase I/II study evaluates AGuIX gadolinium-based nanoparticles in pancreatic and lung cancers

JMT-103 shows safety and efficacy in phase Ib/II study in patients with giant cell tumor of bone

Cardiac troponin I has predictive potential for ICU admission and mortality in COVID-19 patients

Noncovalent approach using monobodies selectively recognizes and inhibits oncogenic RAS mutants

Initial first-in-human data presented for TNO-155

New PPARgamma agonist shows promise in neurodegenerative diseases

FDA issues clinical hold letter for Ortho Regenerative Technologies' ORTHO-R

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.